Prostate Cancer

In this video, Matthew Zibelman, MD, associate professor at the department of hematology/oncology at Temple University Fox Chase Cancer Center, discusses some of the more consequential studies on prostate cancer at ASCO Annual Meeting.

Active systemic cancer treatment did not appear associated with increased mortality among patients with cancer and COVID-19, according to study results published in JAMA Network Open.

In this video, Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic, discusses a new study regarding metastatic prostate cancer presented at ASCO Annual Meeting.

As the number of cancer survivors in the U.S. tops 18 million, ensuring quality care for this aging population remains a challenge, according to a study published in CA: A Cancer Journal for Clinicians.

In this video, Tanya Dorff, MD, head of the genitourinary cancers program at City of Hope, discusses data from the MAGNITUDE study in prostate cancer presented at ASCO Annual Meeting.

In this video, Tanya Dorff, MD, head of the genitourinary cancers program at City of Hope, discusses recent developments related to PARP inhibitors and their effect on prostate cancer presented at ASCO Annual Meeting.

In this video, Tanya Dorff, MD, head of the genitourinary cancers program at City of Hope, discusses results from studies covering lutetium-PSMA-617, two of which were major features in the prostate cancer section at ASCO Annual Meeting.

Men, older patients and patients with low income were among those with elevated risk for CVD hospitalization prior to receiving a diagnosis of potentially curable cancer, researchers reported.

In this video, Tanya Dorff, MD, head of the genitourinary cancers program at City of Hope, discusses results from the ENZAMET trial, updated at ASCO Annual Meeting 3 years after it was first presented.

CHICAGO — Lutetium Lu 177 vipivotide tetraxetan is a viable option for certain men with advanced prostate cancer, according to study results presented at ASCO Annual Meeting.